Editorial of Special Column on A New Era of Nanobiomaterial-based Drug Delivery.
作者信息
Yu Haijun, Qian Zhiyong
机构信息
Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center of Biotherapy, Chengdu 610041, China.
出版信息
Acta Pharm Sin B. 2022 Sep;12(9):3453-3455. doi: 10.1016/j.apsb.2022.08.002. Epub 2022 Sep 20.
Abstract
摘要
相似文献
1
Editorial of Special Column on A New Era of Nanobiomaterial-based Drug Delivery.
Acta Pharm Sin B. 2022 Sep;12(9):3453-3455. doi: 10.1016/j.apsb.2022.08.002. Epub 2022 Sep 20.
2
Editor Profiles: Guest Editors of Special Column on A New Era of Nanobiomaterial-based Drug Delivery.
Acta Pharm Sin B. 2022 Jun;12(6):2623. doi: 10.1016/j.apsb.2022.05.013. Epub 2022 Jun 9.
3
Editorial of Special Column on RNA Therapeutics and Drug Delivery Technologies for Medical Applications.
Acta Pharm Sin B. 2023 Apr;13(4):1346-1347. doi: 10.1016/j.apsb.2023.03.005. Epub 2023 Mar 8.
4
The Chemo-Biological Outreach of Nano-Biomaterials: Implications for Tissue Engineering and Regenerative Medicine.
Curr Pharm Des. 2017;23(24):3538-3549. doi: 10.2174/1381612823666170503144643.
5
Editorial of Special Column on Delivery Nanotechnologies to Modulate the Immune System and Combat Inflammation and Infection.
Acta Pharm Sin B. 2023 Jun;13(6):2296-2297. doi: 10.1016/j.apsb.2023.05.027. Epub 2023 Jun 28.
6
Characterization of a novel nanobiomaterial fabricated from HA, TiO and AlO powders: an in vitro study.
Prog Biomater. 2014 Jun 14;3(1):25. doi: 10.1007/s40204-014-0025-8.
7
Advanced nanobiomaterial strategies for the development of organized tissue engineering constructs.
Nanomedicine (Lond). 2013 Apr;8(4):591-602. doi: 10.2217/nnm.13.46.
8
Editorial of special column on Drug targets and drug development for Alzheimer's disease.
Acta Pharm Sin B. 2022 Apr;12(4):1686-1687. doi: 10.1016/j.apsb.2022.03.007. Epub 2022 Apr 22.
9
Editorial on Special Issue "New Era in the Volume Phase Transition of Gels".
Gels. 2022 Jun 30;8(7):411. doi: 10.3390/gels8070411.
10
Editorial of Special Column on Drug- and Chemical-Induced Liver Injury.
Acta Pharm Sin B. 2021 Dec;11(12):3684. doi: 10.1016/j.apsb.2021.12.004. Epub 2021 Dec 30.
本文引用的文献
1
Multi-functional vesicles improve eradication by a comprehensive strategy based on complex pathological microenvironment.
Acta Pharm Sin B. 2022 Sep;12(9):3498-3512. doi: 10.1016/j.apsb.2022.05.014. Epub 2022 May 16.
2
Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma.
Acta Pharm Sin B. 2022 Sep;12(9):3486-3497. doi: 10.1016/j.apsb.2022.05.016. Epub 2022 May 20.
3
Combination therapy using microwave ablation and d-mannose-chelated iron oxide nanoparticles inhibits hepatocellular carcinoma progression.
Acta Pharm Sin B. 2022 Sep;12(9):3475-3485. doi: 10.1016/j.apsb.2022.05.026. Epub 2022 May 29.
4
Critical involvement of lysyl oxidase in seizure-induced neuronal damage through ERK-Alox5-dependent ferroptosis and its therapeutic implications.
Acta Pharm Sin B. 2022 Sep;12(9):3513-3528. doi: 10.1016/j.apsb.2022.04.017. Epub 2022 May 10.
5
Mucosal vaccine delivery: A focus on the breakthrough of specific barriers.
Acta Pharm Sin B. 2022 Sep;12(9):3456-3474. doi: 10.1016/j.apsb.2022.07.002. Epub 2022 Jul 6.
6
Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma.
Acta Pharm Sin B. 2022 Jun;12(6):2731-2739. doi: 10.1016/j.apsb.2021.10.009. Epub 2021 Oct 22.
7
Enzyme-instructed and mitochondria-targeting peptide self-assembly to efficiently induce immunogenic cell death.
Acta Pharm Sin B. 2022 Jun;12(6):2740-2750. doi: 10.1016/j.apsb.2021.07.005. Epub 2021 Jul 14.
8
A BRD4 PROTAC nanodrug for glioma therapy the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization.
Acta Pharm Sin B. 2022 Jun;12(6):2658-2671. doi: 10.1016/j.apsb.2022.02.009. Epub 2022 Feb 16.
9
Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy.
Acta Pharm Sin B. 2022 Jun;12(6):2710-2730. doi: 10.1016/j.apsb.2021.08.021. Epub 2021 Sep 10.
10
A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy.
Acta Pharm Sin B. 2022 Jun;12(6):2683-2694. doi: 10.1016/j.apsb.2021.10.019. Epub 2021 Oct 26.
Zotero 插件